[144] AMBARELLA INC SEC Filing
Rhea-AI Filing Summary
Form 144 notice: An insider filing indicates proposed and recent sales of Ambarella Inc. common stock under Rule 144. The notice lists a proposed sale of 829 shares through Morgan Stanley Smith Barney on 09/18/2025 on NASDAQ with an aggregate market value of $68,392.50. Acquisition data show 611 shares received as restricted stock on 09/15/2025 and 218 shares purchased via an Employee Stock Purchase Plan on 03/15/2024. Recent sales by the filer, Christopher Day at the Santa Clara address, total 5,551 shares across four transactions from 07/14/2025 to 09/17/2025 with gross proceeds reported.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Rule 144 insider sale notice showing modest insider dispositions across recent months.
The filing documents a proposed sale of 829 shares and prior insider sales totaling 5,551 shares between July and September 2025. The broker identified is Morgan Stanley Smith Barney and the trades are on NASDAQ. The acquisitions include restricted stock and ESPP purchases, which explains the mix of acquisition dates and payment types. This filing is procedural disclosure of insider sales rather than an operational update.
TL;DR: Disclosure appears compliant with Rule 144 requirements; no material adverse information reported.
The signer affirms no undisclosed material adverse information and provides acquisition and payment details for the securities being sold. Dates and nature of acquisitions (restricted stock and ESPP) are provided, and recent sales list gross proceeds. The filing contains standard attestations and broker information, consistent with routine insider reporting obligations.